Conference item

Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Wordsworth, P., Claudepierre, P., Loza, E., Olivieri, I., Keat, A., Mantika, I., Wong, R., Kron, M., Kupper, H., & Rudwaleit, M. (2008). Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody. 47, II72–II73.

MLA Style

Wordsworth, P, et al. “Adalimumab Is Effective and Well-Tolerated in Patients with Ankylosing Spondylitis (AS) in Day-to-Day Clinical Practice - Results from Rhapsody.” vol. 47, 2008, pp. II72–II73.

Chicago Style

Wordsworth, P, P Claudepierre, E Loza, et al. 2008. “Adalimumab Is Effective and Well-Tolerated in Patients with Ankylosing Spondylitis (AS) in Day-to-Day Clinical Practice - Results from Rhapsody.” 47: II72–II73.
Print

Authors

+ Wordsworth, P More by this author

Role:: Author

+ Claudepierre, P More by this author

Role:: Author

+ Loza, E More by this author

Role:: Author

+ Olivieri, I More by this author

Role:: Author

+ Keat, A More by this author

Role:: Author

More authors...

Host title:: RHEUMATOLOGY
Volume:: 47
Pages:: II72-II73
Publication date:: 2008-04-01
ISSN:: 1462-0324

Pubs id:: pubs:109183
UUID:: uuid:06745399-c193-40f0-bccc-84cce00a207d
Local pid:: pubs:109183
Source identifiers:: 109183
Deposit date:: 2013-11-17
ARK identifier:: ark:/29072/ora_06745399c19340f0bccc84cce00a207d

Terms of use

Copyright date:: 2008

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP